Showing results (351-360 of 423) with videos related to
Sort By:
Pageof 43
Psychological Medicine|September 26, 2018
Deficient auditory predictive coding during vocalization in the psychosis risk syndrome and in early illness schizophrenia: the final expanded sampleDaniel H Mathalon, Brian J Roach, Jamie M Ferri, et al.Biochemical Society Transactions|October 25, 2000
Genomic organization and gene function in LeishmaniaP J Myler, E Sisk, P D McDonagh, et al.The Journal of Biological Chemistry|August 26, 1998
Characterization of interactions between the anti-apoptotic protein BAG-1 and Hsc70 molecular chaperonesJ K Stuart, D G Myszka, L Joss, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumorsJason M God, Christine Cameron, Janette Figueroa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumorsK N Bhalla, G N Kumar, U K Walle, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2004
Characterization of a highly polymorphic marker adjacent to the SLC4A1 gene and of kidney immunostaining in a family with distal renal tubular acidosisChairat Shayakul, Petr Jarolim, Marie Zachlederova, et al.Frontiers in Microbiology|August 23, 2013
Impact of DNA damaging agents on genome-wide transcriptional profiles in two marine Synechococcus speciesSasha G Tetu, Daniel A Johnson, Deepa Varkey, et al.Medical Oncology (Northwood, London, England)|March 14, 2000
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trialA A Ezzat, E M Ibrahim, R K Stuart, et al.Bone Marrow Transplantation|April 10, 2012
Growth factor plus preemptive ('just-in-time') plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposureL J Costa, J Abbas, K R Hogan, et al.The ISME Journal|October 27, 2015
Cyanobacterial reuse of extracellular organic carbon in microbial matsRhona K Stuart, Xavier Mayali, Jackson Z Lee, et al.Pageof 43